Latest Stock Split Details
Key information about Catabasis Pharmaceuticals, Inc.'s most recent stock split
Split Date: 2021-08-19
Split Ratio: 1:6
Price Before Split: $0.20
Price After Split: $0.03
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 6.00 times fewer shares (a 1:6 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Catabasis Pharmaceuticals, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2021-08-19 | 1:6 | Yes | $0.20 | $0.03 |
| 2018-12-31 | 1:10 | Yes | $0.07 | $0.01 |
About Catabasis Pharmaceuticals, Inc.
Company overview and industry information
Catabasis Pharmaceuticals, Inc. (CATB) operates in the Biotechnology industry. The recent 1-for-6 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Catabasis Pharmaceuticals, Inc. Summary